MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
H Horn, M Ziepert, C Becher, TFE Barth… - Blood, The Journal …, 2013 - ashpublications.org
… the integration of MYC protein expression and the MYC translocation status into existing …
expression (or MYC rearrangement status) in concert with BCL2high and BCL6low status …
expression (or MYC rearrangement status) in concert with BCL2high and BCL6low status …
Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCL
L Li, X Zhang, T Zhang, Z Song, G Hu, W Li, L Li… - … Myeloma and Leukemia, 2018 - Elsevier
… Simultaneously, we found BCL-2 + /MYC + expression was … BCL-2 + expression and MYC
− expression showed a trend … MYC expression in concert with BCL2 and BCL6 expression …
− expression showed a trend … MYC expression in concert with BCL2 and BCL6 expression …
BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients
… frequency of BCL2, BCL6, IGH, TP53, and MYC protein expression and rearrangements
of the … BCL6 was the most rearranged gene (63.6%), followed by MYC (31.8%), TP53 (22.7%), …
of the … BCL6 was the most rearranged gene (63.6%), followed by MYC (31.8%), TP53 (22.7%), …
MYC, BCL2, BCL6 in DLBCL: impact for clinics in the future?
C Thieblemont, J Briere - Blood, The Journal of the American …, 2013 - ashpublications.org
… , MYC in concert with BCL6 and BCL2 appear to have a role to play in refractory/relapsed
DLBCL. MYC … MYC status in concert with BCL2 and BCL6 expression predicts outcome in …
DLBCL. MYC … MYC status in concert with BCL2 and BCL6 expression predicts outcome in …
MYC, BCL2, and BCL6 expression as prognostic indicators in primary central nervous system lymphoma: a systematic review and meta-analysis
L Ge, S Lu, L Xu, H Yan - Clinical Neurology and Neurosurgery, 2021 - Elsevier
… Cohort studies discussing the prognostic impact of MYC, BCl2, or BCL6 genetic alterations
or gene expression in PCNSL were selected. The pooled hazard ratio (HR) and median …
or gene expression in PCNSL were selected. The pooled hazard ratio (HR) and median …
Correlation between C-MYC, BCL-2, and BCL-6 protein expression and gene translocation as biomarkers in diagnosis and prognosis of diffuse large B-cell lymphoma
YX Zhang, H Wang, C Ren, H Yu, W Fang… - Frontiers in …, 2019 - frontiersin.org
… antibodies against CD10, IRF4/MUM1, and BCL6. Those with the number of CD10 positive
cells greater than 30%, as well as BCL6 positive belong to the germinal center B cell subtype…
cells greater than 30%, as well as BCL6 positive belong to the germinal center B cell subtype…
[HTML][HTML] Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma
Q Ye, ZY Xu-Monette, A Tzankov, L Deng, X Wang… - Oncotarget, 2016 - ncbi.nlm.nih.gov
… The prognosis of concurrent MYC and BCL6 translocations is … rearrangements and expression
of MYC, BCL2 and BCL6 in … no MYC translocation but without BCL2 translocation status …
of MYC, BCL2 and BCL6 in … no MYC translocation but without BCL2 translocation status …
Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B‐cell lymphoma treated with cyclophosphamide, doxorubicin …
N Akyurek, A Uner, M Benekli, I Barista - Cancer, 2012 - Wiley Online Library
… MYC rearrangement status, (B) BCL6 rearrangement status, and (C) BCL2 rearrangement
status… a correlation between BCL6 rearrangement and BCL6 protein expression, consistent …
status… a correlation between BCL6 rearrangement and BCL6 protein expression, consistent …
MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified
LX Yan, YH Liu, DL Luo, F Zhang, Y Cheng, XL Luo… - PLoS …, 2014 - journals.plos.org
… of MYC, BCL2 and BCL6 expression, … MYC/BCL2 DHS, high MYC/BCL6 DHS and high
THS had multiple adverse prognostic factors including high LDH level, poor performance status, …
THS had multiple adverse prognostic factors including high LDH level, poor performance status, …
Does cell-of-origin or MYC, BCL2 or BCL6 translocation status provide prognostic information beyond the International Prognostic Index score in patients with …
M Schmidt-Hansen, S Berendse, T Marafioti… - Leukemia & …, 2017 - Taylor & Francis
… with MYC translocation status and/or gene expression profile-… with MYC translocation status
and gene expression profile-… cell-of-origin/MYC translocation status covariate and in other …
and gene expression profile-… cell-of-origin/MYC translocation status covariate and in other …
相关搜索
- concert with bcl2 bcl6 expression
- prognostic indicators bcl6 expression
- concurrent expression of myc and bcl2
- double expression of myc and bcl2
- myc expression and translocation
- dual expression of myc and bcl2
- myc protein expression
- concurrent myc expression in de novo
- myc bcl2 co-expression
- large b cell lymphoma bcl6 expression
- outcome in chinese patients bcl6 expression
- system lymphoma bcl6 expression
- meta analysis bcl6 expression
- systematic review bcl6 expression
- cns relapse dual expression of myc
- phase iii goya study myc expression